Company intelligence / Profile preview

ICIG Ventures

Frankfurt am Main, Hesse, Germanyic-investors.com ↗

Ownership: Private
Development stage: Other

Overview

ICIG Ventures is the corporate venture capital arm of International Chemical Investors Group. It invests in early-stage startups focused on industrial biotechnology, chemistry, advanced materials, energy innovations, and food & agriculture. The firm typically participates from seed to Series B rounds with investments between €0.25 million and €5 million per deal. Its geographic focus includes Europe, North America, and Israel but can extend globally for strategic opportunities. Portfolio companies benefit from access to pilot-scale production capabilities and industry expertise[1][4].

Industry: Investors

Partnerships

Unconventional Ventures (syndication partner)Joyance Partners (syndication partner)

Beyond the preview

Go deeper on ICIG Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICIG Ventures.

Explore the full profile